Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer
Kamachi, S.; Sakurabayashi, I.; Kawai, T.
Rinsho Byori. Japanese Journal of Clinical Pathology 32(7): 781-785
1984
ISSN/ISBN: 0047-1860 PMID: 6389940 Document Number: 232154
Document emailed within 1 workday
Related Documents
Yamaguchi, K.; Tanaka, M.; Kitagawa, N.; Kotake, T.; Yanagi, S.; Ito, H. 1989: The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers Hinyokika Kiyo. Acta Urologica Japonica 35(6): 987-991Akiyama, K.; Nakamura, T.; Iwanaga, S.; Hara, M. 1988: On the chymotrypsin-like activity of prostate specific antigen, gamma-seminoprotein (gamma-Sm)--forensic immunological studies of body fluids and secretions, Report XXXV Nihon Hoigaku Zasshi 42(2): 154-160
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Rodríguez Duarte, C. 1991: Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients Archivos Espanoles de Urologia 44(6): 697-700
Leewansangtong, S.; Soontrapa, S.; Tantiwong, A. 1999: Is prostate-specific antigen still the best tumor marker for prostate cancer? Journal of the Medical Association of Thailand 82(10): 1034-1040
Tsuda, R.; Hara, M.; Inoue, T.; Okabe, T. 1983: Immunochemical localization of gamma-seminoprotein and beta-microseminoprotein in prostatic glands--forensic immunological studies of body fluids and secretion: report XIX Nihon Hoigaku Zasshi 37(1): 16-19
Tsuda, R.; Iki, H.; Kamachi, S.; Hara, M. 1985: Demonstration of seminal stains by enzyme immunoassay using peroxidase-conjugated anti-gamma-seminoprotein (gamma-Sm) Fab'--forensic immunological studies of body fluids and secretion, report XXIV Nihon Hoigaku Zasshi 39(1): 30-34
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26
Debets, J.M.; Van de Winkel, J.G.; Ceuppens, J.L.; Dieteren, I.E.; Buurman, W.A. 1990: Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase Journal of Immunology 144(4): 1304-1310
Rahardjo, D.; Kamil, S.T.; Pakasi, L.S. 2000: Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 563-570
Narita, D.; Cimpean, A.M.; Anghel, A.; Raica, M. 2006: Prostate-specific antigen value as a marker in breast cancer Neoplasma 53(2): 161-167
Herranz Amo, F.; Díez Cordero, J.M.; Verdú Tartajo, F.; Lledó García, E.; Subirá Castillón, C.; González Chamorro, F.; Rodríguez Fernández, E. 1997: Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer Archivos Espanoles de Urologia 50(3): 253-258
Walsh, P.C.; Oesterling, J.E.; Epstein, J.I.; Bruzek, D.J.; Rock, R.C.; Chan, D.W. 1989: The value of prostate-specific antigen in the management of localized prostatic cancer Progress in Clinical and Biological Research 303: 27-33
Ito, K.; Ohtake, N.; Hatori, M.; Mashimo, T.; Jimbo, S.; Tomaru, Y.; Makino, T.; Yajima, H.; Imai, K.; Yamanaka, H. 1992: Prostatic specific antigen (PA) in mass screening for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1225-1229
Sheth, A.R.; Garde, S.V.; Mehta, M.K.; Shah, M.G. 1992: Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide Indian Journal of Experimental Biology 30(3): 157-161
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Otnes, B.; Harvei, S.; Fosså, S.D. 1996: Increased incidence of prostatic cancer. the significance of prostate-specific antigen Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(15): 1795-1799
Badalament, R.A.; Drago, J.R. 1989: Correlation of prostatic specific antigen with Gleason grade in prostate cancer In Vivo 3(6): 381-382
Mazo, E.B.; Sergeeva, N.A.; Grigor'ev, M.E.; Lebedev, D.V.; Solov'eva, E.V.; Konorev, V.A.; Krovets, A.A. 2006: Comparative value of molecular forms of prostate-specific antigen in diagnosis of prostatic cancer Urologiia 3: 21-24